SEC Form 4 · accession 0000899243-17-006491
Enova International, Inc. · ENVA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven E Cunningham
Officer — VP - CFO and Treasurer
Period of report
Feb 17, 2017
Accepted (ET)
Mar 3, 2017 · 7:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001529864
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock, par value $0.00001 per shareF1,F2 | Feb 17, 2017 | A | 29,392 | $0.00 | A | 133,358 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy) with limited SARF3,F4,F5 | $14.80 | Feb 17, 2017 | A | 65,910 | A | — | Feb 17, 2024 | Common stock, par value $0.00001 per share | 65,910 | 65,910 | D |
Explanation of responses
- F1Reflects a grant of Restricted Stock Units ("RSUs") that shall vest in substantially equal one-fourth increments on each of the following dats as long as grantee serves as an employee of Enova International, Inc. ("Issuer") or an affiliate through the applibable vesting date: February 17, 2018, February 17, 2019, February 17, 2020, and February 17, 2021.
- F2Includes a grant of RSUs that shall vest in substantially equal one-fourth increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: June 22, 2017, June 22, 2018, June 22, 2019, and June 22, 2020.
- F3The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.
- F4The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Enova representing at least 30% of the total voting power of the stock of Enova, or an offer to purchase assets from Enova that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Enova, other than an offer made by Enova.
- F5The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: February 17, 2018, February 17, 2019, and February 17, 2020.